Bo Ahrén
141 – 150 of 398
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.
- Contribution to journal › Article
-
Mark
Are Sulfonylureas Less Desirable Than DPP-4 Inhibitors as Add-on to Metformin in the Treatment of Type 2 Diabetes?
- Contribution to journal › Article
-
Mark
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.
- Contribution to journal › Article
-
Mark
The future of incretin-based therapy: novel avenues-novel targets.
- Contribution to journal › Article
- 2010
-
Mark
Study on administration of 1,5-anhydro-D-fructose in C57BL/6J mice challenged with high-fat diet
- Contribution to journal › Article
-
Mark
A paleolithic diet is more satiating per calorie than a mediterranean-like diet in individuals with ischemic heart disease.
- Contribution to journal › Article
-
Mark
Overexpression of Foxf2 in adipose tissue is associated with lower levels of IRS1 and decreased glucose uptake in vivo
- Contribution to journal › Article
-
Mark
Disassociated relation between plasma tumor necrosis factor-alpha, interleukin-6 and increased body weight in Amerindian women: A long-term prospective study of natural body weight variation and impaired glucose tolerance
- Contribution to journal › Article
-
Mark
Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice
- Contribution to journal › Article
-
Mark
Changes in Prandial Glucagon Levels after 2-year Treatment with Vildagliptin or Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy.
- Contribution to journal › Article